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Highlights 
 The study provides a comprehensive and quantitative review of IGF-1 and delirium. 
 IGF-1 might play a role in the pathogenesis in the delirium. 
 Lower peripheral levels of IGF-1 could be associated with delirium in the elderly. 
 
Abstract:  
Introduction: Delirium, a serious condition observed in critically ill patients, clinically 
presents with impaired cognition and consciousness. The relationship between delirium and 
peripheral levels of insulin growth factor-1 (IGF-1) is unclear. Thus we conducted a meta-
analysis to address this issue. 
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Methods: Seven major electronic databases were searched from inception until October 2, 2017 
to obtain relevant clinical variables to compare the difference in IGF-1 levels between delirious 
and non-delirious elderly in-patients. A random effects meta-analysis was conducted. 
Results: We studies 10 articles involving 294 delirious patients (mean age 73.0 years) and 604 
non-delirious patients (mean age 76.9 years). We found that peripheral levels of IGF-1 in 
patients with delirium were significantly lower than in those without delirium (Hedges` g = -
0.209, 95% confidence interval [CI] = -0.393 to -0.026, p = 0.025). Meta-regression analyses 
found that no variables such as percentage of cognitive impairment, mean age, and female 
proportion contribute to heterogeneity in terms of the entire population. 
Conclusions: Our data suggests that lower peripheral levels of IGF-1 could be associated with 
a higher incidence of delirium among elderly patients. Further prospective studies with larger 
sample sizes are needed to investigate the association between peripheral levels of IGF-1 and 
delirium. 
Abbreviation: CI: confidence interval; IGF-1: insulin-like growth factor-1 
 
Keywords: Biomarker; Delirium; Elderly; IGF-1; Meta-analysis 
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1. Introduction 
Delirium, which clinically presents with impairment in cognition, consciousness, 
psychomotor behavior, and attention (Ely et al., 2001), may manifest with a wide range of 
subtypes ranging between hyperactive and hypoactive conditions (Steiner, 2011). Clinically, 
it usually presents with a sudden onset, which then fluctuates between hours and days and is 
generally a reversible condition (Yudofsky & Hales, 2008). Etiologically, delirium indicates 
an organic decline in cerebral function resulting from variable mechanisms. For example, the 
etiology of alcohol-withdrawal delirium differs from that causing postoperative delirium 
(Steiner, 2011). Incidence of delirium varies depending on the purpose of investigation. 
Incidence of delirium varies between 9% and 43% among geriatric patients hospitalized for 
variable medical conditions (Laurila, Pitkala, Strandberg, & Tilvis, 2002; O'Keeffe & 
Gosney, 1997). Delirium is commonly observed in elderly patients post surgery, and the 
incidence of postoperative delirium (POD) ranges widely between 10% and 65% (Radtke et 
al., 2010; Rudolph & Marcantonio, 2011). Delirium is a serious neuropsychiatric condition 
with a substantial impact owing to increased morbidity and mortality, high healthcare costs 
and prolonged hospitalization associated with it (Hustey, Meldon, Smith, & Lex, 2003; 
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Meagher et al., 2007). Regarding mortality rates, reportedly, delirious patients show an 
overall hazard ratio of 1.9 in elderly patients in a meta-analysis study (Witlox et al., 2010). 
Given the inadequate understanding of its multifactorial aetiopathogenesis (Hughes, Patel, & 
Pandharipande, 2012), researchers are interested in studying the etiology of delirium to better 
predict its course and prognosis in clinical settings. Although previous reviews (Khan, 
Zawahiri, Campbell, & Boustani, 2011) have demonstrated the limited role of biomarkers in 
detection of delirium, researchers have been trying to identify specific biomarkers linked to 
this condition such as insulin growth factor-1 (IGF-1).  
IGF-1 is a member of the IGF family with 70 amino acid peptides, and is primarily 
produced in the central nervous system (CNS) and peripheral tissues such as the liver (Le 
Roith, 2003; Torres-Aleman, 2010). IGF-1 in the CNS plays a vital role in enhancing 
neuronal survival, differentiation, synaptogenesis, and recovery from neural injury (D'Ercole, 
Ye, & O'Kusky, 2002). IGF-I blocks apoptosis in damaged neurons via several mechanisms, 
such as delay of apoptosis via activation of PI3K/Akt kinase and Ras/Raf/MEK/ERK 
pathways and results in long-term survival (Gluckman et al., 1998; Parrizas & LeRoith, 1997; 
Peruzzi et al., 1999). Clinically, studies have explored its neuroprotective role and association 
with neurocognitive disorders such as Alzheimer’s disease (AD), of which is involved with 
delirium (Kooijman, Sarre, Michotte, & De Keyser, 2009; Lackey, Gray, & Henricks, 2000). 
Additionally, IGF-1 deficiency in humans may cause growth abnormalities, including a 
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smaller sized brain and mental retardation (Werner & LeRoith, 2014). Furthermore, it has 
been reported that serum IGF-1 levels positively correlate with cognitive performance in 
healthy elderly subjects (Al-Delaimy, von Muhlen, & Barrett-Connor, 2009; Aleman et al., 
2000). 
Moreover, as researchers keenly investigating the association between peripheral levels of 
IGF-1 and delirium, several studies have explored the significance of this correlation in 
patients undergoing surgery or those with acute medical illnesses (Adamis et al., 2009; 
Adamis et al., 2007; Cerejeira, Batista, Nogueira, Vaz-Serra, & Mukaetova-Ladinska, 2013; 
Egberts et al., 2015; Lemstra, Kalisvaart, Vreeswijk, van Gool, & Eikelenboom, 2008; 
Morandi et al., 2011; Wilson, Broadhurst, Diver, Jackson, & Mottram, 2005). While some 
studies report that lower peripheral levels of IGF-I could significantly increase the incidence 
of delirium (Cerejeira et al., 2013; Egberts et al., 2015; Morandi et al., 2011; Wilson et al., 
2005), the opposite findings have also been reported by some others (Adamis et al., 2009; 
Adamis et al., 2007; Lemstra et al., 2008). Possible factors accounting for this discrepancy are 
inconsistency between recruited patients, such as postoperative or medically ill cases in terms 
of study designs or clinical status. Thus, the association between peripheral levels of IGF-I 
and incidence of delirium in a clinical setting needs to be further studied. Given these 
aforementioned gaps existing in literature, we performed a comprehensive systematic review 
and meta-analysis investigating the association between peripheral levels of IGF-1 and 
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delirium, specifically focusing on clinical status of patients. In addition to exploring the 
difference in this association between surgical or medically ill patients, we also attempted to 
determine possible factors affecting the correlation between delirium and IGF-1 levels. 
2. Materials and methods 
Our systematic review and meta-analysis was based on Meta-analysis Of Observational 
Studies in Epidemiology (MOOSE) guidelines (Stroup et al., 2000) (supplemental table S1) 
and was approved by the Institutional Review Board of the Tri-Service General Hospital 
(TSGHIRB: B-105-12). Two investigators (DJ Li and CS Chu) independently performed 
database searches, study selection, data extraction, and rating of the methodological quality of 
included studies. Disagreements between investigators were resolved thorough consensus. 
2.1. Database searches 
PubMed, Embase, ScienceDirect, ClinicalKey, Cochrane Library, ClinicalTrials.gov and 
ProQuest were systematically searched from the time of their inception until October 2nd, 
2017. Keywords used for our search included “(IGF OR IGF1 protein OR inflammation 
mediators OR insulin-like growth factor OR cytokine) AND (delirium OR acute confusion 
OR consciousness disturbance)” without any limitation about language. Detailed search 
strings used for the electronic database search and results are shown in the supplemental 
figure S1.  
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2.2. Eligibility Criteria and Study Selection 
Eligibility criteria applied were: (1) case-control studies comparing peripheral IGF-1 levels 
between delirious patients and non-delirious controls, or cohorts with detailed baseline data 
and subsequent delirium risk; (2) those with a diagnosis of delirium based on the definite 
diagnostic systems or scales, such as confusion assessment method (CAM) (Inouye et al., 
1990), the diagnostic and statistical manual of mental disorders, 3rd revision (American 
Psychiatric Association. 1980) and text-revision (DSM-IV-TR) (American Psychiatric 
Association. 2000), or Delirium observation screening scale (Schuurmans, Shortridge-
Baggett, & Duursma, 2003), Richmond agitation-sedation scale (Sessler et al., 2002); (3) 
those in whom detailed methods for detecting peripheral IGF-1 were available; and (4) formal 
registered trials or formal published peer-reviewed articles. 
Exclusion criteria were: (1) studies without adequate non-delirious controls; (2) articles 
without relation to the comparisons of peripheral IGF-1 levels in delirious patients and 
controls; (3) those irrelevant to delirium; (4) review articles/commentary articles/case 
reports/letter to editor; or (5) non-clinical trials in human. 
2.3. Methodological Quality Assessment 
The modified Newcastle-Ottawa Scale (NOS) was used to rate methodological quality of 
included studies (Wells GA). This scale considers three domains: selection of participants 
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(maximum of four stars), comparability of groups (maximum of two stars), and measurement 
(maximum of three stars). Scores ranged from 0 (the lowest) to 9 (the highest), and a score 
equal to 7 indicated high methodological quality. 
2.4. Data Extraction 
A predetermined data extraction list was used to extract data for this meta-analysis. To be 
specific, the extracted data included basic characteristics of participants (mean age and 
percentage of female), mini-mental status examination (MMSE), and duration of 
hospitalization.  
2.5. Meta-analysis  
The primary outcomes were the difference in peripheral IGF-1 levels in delirious patients 
compared to control groups who did not develop delirium in each recruited study (calculated 
as Hedges’ g statistic). We did not choose difference in means as effect sizes (ESs) of our 
primary outcome due to presumed different units used among each study. For studies in 
which peripheral levels of IGF-1 were not available, outcomes were chosen as odd ratios 
(ORs) (Morandi et al., 2011; Wilson et al., 2005), or only a p value (Adamis et al., 2007) 
according to manuals of Comprehensive Meta-Analysis version 3.0. When peripheral levels 
of IGF-1 were not available in the included studies, we tried to contact the authors of such 
studies on at least two separate occasions to try and obtain additional raw data. Additionally, 
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we converted ORs into ES using the formula suggested by the Cochrane Handbook (Higgins 
& Green, 2011) and derived ES using other statistical parameters such as the t or p value with 
the sample size when raw data were not available via email inquiry. We defined an ES and 
Hedges’ g less than 0 as “lower peripheral IGF-1 levels in patients with delirium than in 
controls without delirium”. Statistical significance was set as a two-tailed p value < 0.05. All 
meta-analytical procedures were performed using the Comprehensive Meta-Analysis version 
3 (CMA ver. 3.0) (Biostat, Englewood, NJ) software. Meta-analyses were performed using 
random-effects models due to the anticipated heterogeneity across studies. Briefly, random-
effects modeling is more stringent and therefore more convincing than fixed-effects modeling 
and incorporates a between-study variance in the calculations (Borenstein, Hedges, Higgins, 
& Rothstein, 2010).  
2.6. Heterogeneity, publication bias, sensitivity test, and meta-regression 
We used the Cochran’s Q test and the corresponding p value to investigate potential 
heterogeneity among recruited studies (Higgins & Thompson, 2002). The I2 metric was used 
to investigate the proportion of variance between recruited studies (Borenstein, Higgins, 
Hedges, & Rothstein, 2017). The publication bias was determined by visual examination of 
funnel plots in situations of less than 10 studies (Higgins & Green, 2011) and using thorough 
Egger’s regression analysis if there were more than 10 studies (Egger, Davey Smith, 
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Schneider, & Minder, 1997). In situation of significant publication bias, we arranged Duval 
and Tweedie`s trim and fill test to adjust the results of meta-analysis (Duval & Tweedie, 
2000). Additionally, we performed sensitivity testing with one study removal test to 
investigate potential confounding by any one of the outlier in the recruited studies, which had 
been widely used in meta-analysis (Tobias, 1999). Additionally, we performed meta-
regression analysis using an unrestricted maximum likelihood method to explore potential 
moderators. Variables considered for meta-regression analyses were: mean age, female 
gender (%), MMSE score, and a total modified NOS scores. The meta-regression procedure 
was only performed when moderator variables were available from more than 5 individual 
datasets. 
3. Results 
3.1. Studies included in the meta-analysis 
The whole search picture was depicted as figure 1 and supplemental figure S1. In brief, 
eighty-two articles enter the full-texts investigation stage, and seventy-two were excluded for 
specific reasons (see supplemental table S2). Finally, ten articles met our inclusion criteria 
(Adamis et al., 2007; Cerejeira et al., 2013; Chu et al., 2016; Cinar et al., 2014; Egberts et al., 
2015; Lemstra et al., 2008; Morandi et al., 2011; Shen, Shao, Chen, & Guo, 2016; Wilson et 
al., 2005; Yen et al., 2016). Peripheral levels of IGF-1 were obtained before delirium 
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occurring in the seven studies (Cerejeira et al., 2013; Chu et al., 2016; Cinar et al., 2014; 
Lemstra et al., 2008; Shen et al., 2016; Wilson et al., 2005; Yen et al., 2016). The participants 
in other three studies might be drawn IGF-1during delirious status (Adamis et al., 2007; 
Egberts et al., 2015; Morandi et al., 2011). 
3.2. Methodological quality assessment 
The mean modified NOS score was 7.4 with standard deviation (SD) = 0.5 across the ten 
studies. The score in each domain of the modified NOS is shown in supplemental table S3. 
3.3. The main results of the meta-analysis comparing the levels of IGF-1 in patients with 
delirium and those without delirium 
Our systematic review and meta-analysis included 10 articles that met our inclusion 
criteria. Peripheral (serum or plasma) IGF-1 levels were measured in these ten studies. The 
quantitative determination of IGF-1 were taken from plasma (Cerejeira et al., 2013; Wilson et 
al., 2005) and serum (Adamis et al., 2007; Chu et al., 2016; Cinar et al., 2014; Egberts et al., 
2015; Morandi et al., 2011; Shen et al., 2016; Yen et al., 2016), respectively. One study 
(Lemstra et al., 2008) mentioned that IGF-1 was assessed from blood sample (table 1). We 
found 294 delirious patients (mean age 73.0 years, women 51.0 %) and 604 non-delirious 
patients (mean age 76.9 years, women 53.2 %) among the 10 studies. Peripheral levels of 
IGF-1 in patients with delirium were significantly lower than in those without delirium 
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(Hedges’ g = -0.209, 95% confidence interval (CI) = -0.393 to -0.026, p = 0.025] (Figure 2) 
with significant heterogeneity (Q value = 20.215, degree of freedom (df) = 9, I2 = 55.479%, p 
= 0.017) but no significant publication bias based on Egger’s test [t value = 1.060, df = 8, p = 
0.320]. 
3.3.1. Sensitivity test 
The significant result of current meta-analysis became non-significant after removal of the 
datasets by Adamis, D. (2007) (Hedges’ g = -0.184, 95% CI = -0.374 to 0.006, p = 0.058) 
(Adamis et al., 2007), Egberts, A. (2015) (Hedges’ g = -0.175, 95% CI = -0.362 to 0.011, p = 
0.066) (Egberts et al., 2015), Shen, H. (2016) (Hedges’ g = -0.125, 95% CI = -0.262 to 0.012, 
p = 0.073) (Shen et al., 2016), or Yen, T.E. (2016) (Hedges’ g = -0.193, 95% CI = -0.390 to 
0.004, p = 0.055) (Yen et al., 2016). 
3.3.2 Meta-regression 
There was no any significant association between the differences of peripheral IGF-1 and 
clinical variables, including percentage of cognitive impairment (p=0.960), mean age 
(p=0.978), female proportion (p=0.721), mean MMSE scores (p=0.929), or quality of 
methodology as total modified NOS scores (p=0.270). 
4. Discussion 
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To the best of our knowledge, the study is the first meta-analysis to address the association 
between peripheral IGF-1 and delirium and suggests that lower peripheral IGF-1 levels were 
found in patients with delirium compared with those without delirium. Although causality of 
delirium and peripheral levels of IGF-1 has yet to be clarified, our study offers additional 
evidence supporting the immune-inflammatory hypothesis in delirium.  
The link between delirium and peripheral levels of IGF-1 can be mediated by cytokines 
released during inflammatory processes. Reportedly, a strong correlation is seen to exist 
between delirium and inflammation (Broadhurst & Wilson, 2001). Peripheral IGF-1 can cross 
the blood-brain barrier and play a role in neuronal function (Reinhardt & Bondy, 1994). It has 
been reported that administration of IGF-1 reduces secondary neuronal loss after transient 
neural injuries (Gluckman et al., 1998; Trejo, Carro, Garcia-Galloway, & Torres-Aleman, 
2004). Similarly, replacement therapy with IGF-1 ameliorates diabetic neuropathy (Schmidt 
et al., 1999). Our study provides additional evidence to support this hypothesis. Lower 
peripheral levels of IGF-1 may possess lesser neuroprotective properties that is anti-apoptotic 
and anti-inflammatory actions, and contributed higher risk of delirium.  
Another factor involved in the connection between peripheral levels of IGF-1 and delirium 
may be relatively high mean age (almost above 70 years old) of participants in the included 
studies. Ageing, resulting from increased natural immunity activity, is a low level 
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inflammatory status (Godbout & Johnson, 2009; Licastro et al., 2005). Inflammation is 
related to several morbid conditions in the elderly such as cardiovascular disease (Pai et al., 
2004) or Alzheimer’s disease (Casserly & Topol, 2004). Furthermore, inflammation may 
result in the breakdown of the blood-brain barrier (Jeppsson et al., 1981) and decrease 
cholinergic transfer(Hammond, Meador, Aung-Din, & Wilder, 1987). Taken together, 
elevated levels of proinflammatory cytokine levels have been suggested to predispose the 
development of delirium in elderly, which is interpreted by the concept of immunosenescence 
(Godbout & Johnson, 2006). IGF-1, involving neuro-inflammation in the CNS (Trejo et al., 
2004), may be also affected by ageing, be associated with delirium. However, our meta-
regression showed that mean age did not significantly involve the relation between delirium 
and IGF-1. In addition to limited case numbers, relatively narrowing distribution of mean age 
may also restrict the statistical significance. Previous study also indicated that older patients 
undergoing cardiovascular surgery may develop delirium easily (Cinar et al., 2014). However, 
clearly more research is required to better understand this issue. 
It has been reported that IGF-1 levels positively correlate with cognitive performance in 
healthy elderly subjects (Al-Delaimy et al., 2009; Aleman et al., 2000). A meta-analysis has 
reported a significantly positive correlation between IGF-I and cognition in a healthy elderly 
population (Arwert, Deijen, & Drent, 2005). Another study concluded that the IGFI levels 
showed an inverse correlation with cognitive dysfunction (Murialdo et al., 2001). In the 
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present meta-analysis study, only two studies enrolled participants with baseline cognitive 
healthy, which was defined as an MMSE score of ≧ 24 or excluded when enrollment, and 
reported that lower peripheral levels of IGF-1 associated with incident of delirium in one 
study (adjusted Odd ratios [aORs] = 2.52, 95% CI = 1.19 to 5.43, p = 0.019)(Shen et al., 
2016) but not another (aORs = 0.99, 95% CI = 0.96 to 1.01, p = 0.183) (Yen et al., 2016). For 
participants with baseline cognitive impairment, six (Adamis et al., 2007; Cerejeira et al., 
2013; Chu et al., 2016; Cinar et al., 2014; Lemstra et al., 2008; Morandi et al., 2011) out of 
eight (Adamis et al., 2007; Cerejeira et al., 2013; Chu et al., 2016; Cinar et al., 2014; Egberts 
et al., 2015; Lemstra et al., 2008; Morandi et al., 2011; Wilson et al., 2005) studies showed no 
significant differences between peripheral levels of IGF-1 and delirium. Therefore, cognitive 
impairment could be a possible confounder unfavorably affecting the association between 
delirium and peripheral levels of IGF-1. However, our meta-regression showed that baseline 
MMSE scores were not significantly linked to a correlation between delirium and IGF-1. This 
difference may be due to variable statistical methodology between dichotomous grouping 
[normal cognition vs. mild cognitive impairment (MCI) or dementia] and continuous 
variables of baseline MMSE scores. The fact that a limited number of cases were studied 
might contribute to the insignificance observed with respect to baseline MMSE scores. 
Furthermore, some studies report that IGF-I levels were unaltered or increased among 
dementia patients (Nasman et al., 1995; Sara et al., 1982; Tham et al., 1993). A greater 
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number of studies will need to be performed in future to investigate the correlation between 
cognition and IGF-1 to explore this inconsistency. 
Limitations of our study that need to be addressed are: 1) Studying a limited number of 
cases might be a confounding factor impacting the significance of outcomes. 2) Higher mean 
age would restrict the application of our findings to younger adults or adolescents. 3) We 
could not perform subgroup analyses comparing IGF-1 levels in different delirious 
classifications or diagnostic criteria (hypoactive vs hyperactive delirium and only CAM vs 
CAM plus DSM-III or -IV diagnosis) due to not enough studies. Future research is required to 
understand if this influences the relationship observed. 4) Peripheral levels of IGF-1 do not 
actually reflect the brain levels, and thus the pathogenesis between CNS levels of IGF-1and 
incident delirium need to be addressed in future studies. 
5. Conclusion 
In conclusion, lower peripheral levels of IGF-1 appear to be associated with delirium 
among elderly patients. Further studies involving a greater number of participants and wider 
ranges of age would help to investigate the etiology and association between these two 
entities in future. Studies including more baseline variables and more specific description of 
diagnosing method to delirium could help us investigate more covariates and conduct 
subgroup analysis. 
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Table 1 
Summarization of recruited studies in current meta-analysis 
Author (year) Criteria Population or setting 
Delirium 
Non-delirium 
Mean age Female (%) Source IGF (ng/mL) Country 
Yen, T. E. 
(2016) 
CAM + DSM-
IV 
Elective knee arthroplasty 
22 
76 
73.4±5.1 52.0 serum 
57.0±18.6 
68.4±31.6 
USA 
Shen, H. 
(2016) 
CAM + DSM-
IV 
Open abdominal surgery 
36 
104 
70.1±6.4 57.2 serum 
50.4±16.2 
67.0±24.1 
China 
Chu, C. S. 
(2016) 
CAM + DSM-
IV 
Orthopedic surgery 
23 
80 
81.7±4.0 26.2 serum 
97.1±47.4 
96.1±47.6 
Taiwan 
Egberts, A. 
DOSS + 
DSM-IV 
Internal and geriatric ward 23 82.6 53.5 serum *48.1±32.1 Netherland 
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(2015) 63 71.0±43.5 
Cinar, M. A. 
(2014) 
DSM-IV Cardiovascular surgery 
15 
20 
64.2±10.3 25.7 serum 
1.44±1.76 
1.03±1.18 
Turkey 
Cerejeira, J. 
(2013) 
CAM + DSM-
IV 
Elective hip arthroplasty 
37 
64 
73.0±6.3                            50.5 plasma 
*138.3±57.8 
128.2±59.6 
Portugal 
Morandi, A. 
(2011) 
CAM + CAM-
ICU 
Critically ill mechanically ventilated patients 
86 
24 
65 48.2 serum #n/a USA 
Lemstra, A. 
W. 
(2008) 
CAM + DSM-
IV 
Acute or elective hip surgery 
18 
50 
78.9 69.1 blood 
*109.9 
98.4 
Netherland 
Adamis, D. 
(2007) 
CAM Elderly medical unit 
22 
35 
84.6±6.6 67.1 serum 
55.8±33.7 
75.2±33.7 
UK 
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Wilson, K. 
(2005) 
CAM + DSM-
III 
Acute medical ward 
12 
88 
84.5±4.2 69.0 plasma #n/a UK 
 
*: nmol/L convert to ng/ml x 7.63 
#: derived effect sizes from other statistical parameters 
Abbreviation: CAM: confusion assessment method; DOSS: Delirium observation screening scale; ELISA: enzyme-linked immunosorbent assay; IGF: insulin-
like growth factor; n/a: not available; RASS: Richmond agitation-sedation scale; RIA: radioimmunoassay; UK: United Kingdom; USA: United States of 
America. 
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Figure legends: 
 
Figure 1. Flow chart showing the selection strategy and inclusion/exclusion criteria employed in our current meta-analysis. 
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Figure 2. Forest plot of results of pooled effect sizes (Hedges’ g) and 95% confidence intervals (CIs) from pooled results of peripheral levels of insulin growth 
factor-1 (IGF-1) between delirious and non-delirious patients within the entire population. 
 
AC
CE
PT
ED
 M
AN
US
CR
IPT
